Natural antibodies to IL-2

Biotherapy

Volumn 10, Issue 1, 1997, Pages 25-28

  Balsari, Andrea ^a   Caruso, Arnaldo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

HIV; Il 2; Natural antibodies; Neutralizing activity; Realty individuals

Indexed keywords

CYTOKINE; DRUG ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030748111     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02678214     Document Type: Article

References (12)

1. Ishizaka S, Tsujii T. IL-2 antibody production in lupus mice. Cell. Immunol1989; 118: 100-
2. Whitehead RP, Ward D, Hemingway L, Hemstreet GP, Bradley E, Konrad M. Subcutaneus recombinant interleukin 2 in a dose escalating regimen in patients with metastatic renal cell adenocarcinoma. Cancer Res 1990; 15:6708-14.
3. AUegretta M, Atkins MB, Dempsey RA, Bradley EC, Konrad MW, Childs A, Wolfe SN, Mier JW. The development of antiInterleukin-2 antibodies in patients treated with recombinant human inteiieukin-2 (IL-2). y Clin Immunol19;6;6: 481-6.
4. Bost KL, Hahn BH, Saag MS, Shaw GM, Weigent DA, Blalock JE. Individuals infected with HIV possess antibodies against IL-2. Immunology 1988; 65: 611-5.
5. Tuiano A, Balsari A, Viani E, Landolfo S, Zanoni L, Gargiulo F, Caruso A. Natural human antibodies to 7 Interferon interfere with the immunomodulating activity of the lymphokine. Proc NatlAcadSci USA 1992; 89: 4447-51.
6. Ross C, Hansen MB, Schyberg K. Autoantibodies to crude human leukocyte Interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors. Clin Exp Immunol 1990; 82:57-62
7. Svenson M, Poulsen LK, Fomsgaard A, Bendtzen K. IgG Autoantibodies against Interleukin 1 a in sera of normal individuals.Scand J Immunol 1989;29: 489-92.
8. Fomsgaard A, Svenson M, Bendtzen K. Auto-antibodies to tumor necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. ScandJ Immunol 1989;30: 219-23.
9. Monti, E., Pozzi, A., Tiberio, L., Morelli, D., Caruso, A., Villa, M.L., and Balsari, A. Purification of interleukin-2 antibodies from healthy individuals. Immunol. Lett 1993; 36: 261-266.
10. Tiberio, L., Caruso, A., Pozzi, A., Rivoltini, L., Morelli, D., Monti, E., and Balsari, A. The detection and biological activity of human antibodies to IL-2 in normal donors. Scand. J. Immunol 1993; 38: 472-476.
11. Gately MK, Wilson DE, Wong HL. Sinergy between rIL-2 and IL-2 depleted lymphokine-containing supematants in facilitating allogeneic human cytolytic Tlymphocyte response in vitro. J Immunol 1986; 136: 1274-84.
12. Grimm EA, Rosemberg SA. The human lymphokine-activated killer cell phenomenon. Lymphokines 1984;9: 279-85.